

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 9.94135424 |
| 2 | adhesion of symbiont to host cell (GO:0044650) | 9.16040386 |
| 3 | virion attachment to host cell (GO:0019062) | 9.16040386 |
| 4 | angiotensin maturation (GO:0002003) | 8.54735880 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 7.41498158 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.29547816 |
| 7 | adhesion of symbiont to host (GO:0044406) | 7.12745082 |
| 8 | regulation of bile acid biosynthetic process (GO:0070857) | 6.29108548 |
| 9 | vitamin A metabolic process (GO:0006776) | 6.21844625 |
| 10 | epoxygenase P450 pathway (GO:0019373) | 6.03493571 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.96791593 |
| 12 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.84863315 |
| 13 | fructose metabolic process (GO:0006000) | 5.62774598 |
| 14 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.38937977 |
| 15 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.22322685 |
| 16 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.22322685 |
| 17 | endocrine process (GO:0050886) | 5.22322685 |
| 18 | hormone catabolic process (GO:0042447) | 5.21322981 |
| 19 | digestive system process (GO:0022600) | 5.13096800 |
| 20 | positive regulation of pseudopodium assembly (GO:0031274) | 4.96955830 |
| 21 | flavonoid metabolic process (GO:0009812) | 4.90648446 |
| 22 | regulation of systemic arterial blood pressure (GO:0003073) | 4.75106957 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.73850413 |
| 24 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 4.55542802 |
| 25 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.52612236 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 4.50995160 |
| 27 | regulation of pseudopodium assembly (GO:0031272) | 4.46187134 |
| 28 | peptide hormone processing (GO:0016486) | 4.43218773 |
| 29 | antibacterial humoral response (GO:0019731) | 4.42492453 |
| 30 | drug metabolic process (GO:0017144) | 4.39479620 |
| 31 | actin filament depolymerization (GO:0030042) | 4.38166225 |
| 32 | disruption of cells of other organism (GO:0044364) | 4.36386898 |
| 33 | killing of cells of other organism (GO:0031640) | 4.36386898 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.31212885 |
| 35 | antimicrobial humoral response (GO:0019730) | 4.30659306 |
| 36 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.25315905 |
| 37 | NADH metabolic process (GO:0006734) | 4.20272953 |
| 38 | drug catabolic process (GO:0042737) | 4.19657718 |
| 39 | innate immune response in mucosa (GO:0002227) | 4.19494864 |
| 40 | plasma lipoprotein particle assembly (GO:0034377) | 4.16841226 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.14185303 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.13082955 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.08415563 |
| 44 | positive regulation of glycoprotein metabolic process (GO:1903020) | 4.06736828 |
| 45 | glycolipid catabolic process (GO:0019377) | 4.06382251 |
| 46 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 4.04508483 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 4.03505319 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 4.02527603 |
| 49 | urea metabolic process (GO:0019627) | 4.02160018 |
| 50 | urea cycle (GO:0000050) | 4.02160018 |
| 51 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.00764537 |
| 52 | glucuronate metabolic process (GO:0019585) | 3.97383610 |
| 53 | uronic acid metabolic process (GO:0006063) | 3.97383610 |
| 54 | cellular glucuronidation (GO:0052695) | 3.95107841 |
| 55 | positive regulation of respiratory burst (GO:0060267) | 3.93264798 |
| 56 | bile acid and bile salt transport (GO:0015721) | 3.91901971 |
| 57 | desmosome organization (GO:0002934) | 3.89338307 |
| 58 | defense response to fungus (GO:0050832) | 3.87830479 |
| 59 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.87258068 |
| 60 | bicarbonate transport (GO:0015701) | 3.85783933 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.85651412 |
| 62 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.85540837 |
| 63 | phospholipid efflux (GO:0033700) | 3.82582312 |
| 64 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.82496919 |
| 65 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.82496919 |
| 66 | cytidine deamination (GO:0009972) | 3.81194534 |
| 67 | cytidine metabolic process (GO:0046087) | 3.81194534 |
| 68 | cytidine catabolic process (GO:0006216) | 3.81194534 |
| 69 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.81144689 |
| 70 | hemidesmosome assembly (GO:0031581) | 3.79829048 |
| 71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.78044394 |
| 72 | protein-lipid complex assembly (GO:0065005) | 3.77768344 |
| 73 | digestion (GO:0007586) | 3.76840434 |
| 74 | transepithelial transport (GO:0070633) | 3.75631173 |
| 75 | response to nitric oxide (GO:0071731) | 3.74754904 |
| 76 | glucose 6-phosphate metabolic process (GO:0051156) | 3.74490933 |
| 77 | regulation of cGMP metabolic process (GO:0030823) | 3.72745449 |
| 78 | intestinal epithelial cell development (GO:0060576) | 3.71166431 |
| 79 | renal system process involved in regulation of blood volume (GO:0001977) | 3.68972909 |
| 80 | proline biosynthetic process (GO:0006561) | 3.68222735 |
| 81 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.63712342 |
| 82 | cholesterol efflux (GO:0033344) | 3.62679050 |
| 83 | cellular response to nitric oxide (GO:0071732) | 3.61497298 |
| 84 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.59193371 |
| 85 | arginine metabolic process (GO:0006525) | 3.57875712 |
| 86 | mucosal immune response (GO:0002385) | 3.57460637 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.57353452 |
| 88 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.57353452 |
| 89 | nitrogen cycle metabolic process (GO:0071941) | 3.53742672 |
| 90 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.53111264 |
| 91 | alkaloid metabolic process (GO:0009820) | 3.52317196 |
| 92 | ATP synthesis coupled proton transport (GO:0015986) | 3.51732925 |
| 93 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.51732925 |
| 94 | modified amino acid transport (GO:0072337) | 3.51412447 |
| 95 | membrane repolarization during action potential (GO:0086011) | 3.47479616 |
| 96 | regulation of respiratory burst (GO:0060263) | 3.44449324 |
| 97 | hepatocyte apoptotic process (GO:0097284) | 3.43323033 |
| 98 | sperm capacitation (GO:0048240) | 3.41719944 |
| 99 | drinking behavior (GO:0042756) | 3.41397009 |
| 100 | fat-soluble vitamin metabolic process (GO:0006775) | 3.40754855 |
| 101 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.39134811 |
| 102 | sulfate transmembrane transport (GO:1902358) | 3.37526254 |
| 103 | mRNA modification (GO:0016556) | 3.37474591 |
| 104 | vitamin transport (GO:0051180) | 3.35949454 |
| 105 | midgut development (GO:0007494) | 3.35483965 |
| 106 | regulation of keratinocyte proliferation (GO:0010837) | 3.33146936 |
| 107 | lipoprotein metabolic process (GO:0042157) | 3.31964607 |
| 108 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.31374548 |
| 109 | vitamin transmembrane transport (GO:0035461) | 3.29970255 |
| 110 | organ or tissue specific immune response (GO:0002251) | 3.29363843 |
| 111 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.28689196 |
| 112 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.27359112 |
| 113 | cardiac conduction (GO:0061337) | 3.27304335 |
| 114 | homocysteine metabolic process (GO:0050667) | 3.25902840 |
| 115 | ceramide catabolic process (GO:0046514) | 3.23541739 |
| 116 | cholesterol transport (GO:0030301) | 3.23003241 |
| 117 | sterol transport (GO:0015918) | 3.23003241 |
| 118 | regulation of cholesterol esterification (GO:0010872) | 3.21684426 |
| 119 | diacylglycerol metabolic process (GO:0046339) | 3.21611105 |
| 120 | filopodium assembly (GO:0046847) | 3.21159694 |
| 121 | response to hepatocyte growth factor (GO:0035728) | 3.17794248 |
| 122 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.17794248 |
| 123 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.17739428 |
| 124 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.16470372 |
| 125 | neurotransmitter catabolic process (GO:0042135) | 3.16389442 |
| 126 | cellular response to reactive nitrogen species (GO:1902170) | 3.14356369 |
| 127 | keratinocyte proliferation (GO:0043616) | 3.13934249 |
| 128 | tight junction assembly (GO:0070830) | 3.13879556 |
| 129 | glomerular filtration (GO:0003094) | 3.13534384 |
| 130 | negative regulation of B cell apoptotic process (GO:0002903) | 3.11654113 |
| 131 | thyroid hormone metabolic process (GO:0042403) | 3.11585812 |
| 132 | NIK/NF-kappaB signaling (GO:0038061) | 3.09510116 |
| 133 | eosinophil chemotaxis (GO:0048245) | 3.08561714 |
| 134 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.06942446 |
| 135 | sexual reproduction (GO:0019953) | 3.06925935 |
| 136 | regulation of cholesterol homeostasis (GO:2000188) | 3.06919024 |
| 137 | auditory receptor cell differentiation (GO:0042491) | 3.06678124 |
| 138 | glycosylceramide metabolic process (GO:0006677) | 3.05646777 |
| 139 | exogenous drug catabolic process (GO:0042738) | 3.05361931 |
| 140 | respiratory electron transport chain (GO:0022904) | 3.03678685 |
| 141 | * regulation of cellular extravasation (GO:0002691) | 3.01618319 |
| 142 | bile acid metabolic process (GO:0008206) | 3.00884981 |
| 143 | cholesterol homeostasis (GO:0042632) | 2.99596734 |
| 144 | transcytosis (GO:0045056) | 2.99528810 |
| 145 | sphingolipid catabolic process (GO:0030149) | 2.98601779 |
| 146 | sterol homeostasis (GO:0055092) | 2.98497703 |
| 147 | cGMP-mediated signaling (GO:0019934) | 2.98337989 |
| 148 | regulation of digestive system process (GO:0044058) | 2.98284154 |
| 149 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.97726597 |
| 150 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.97238366 |
| 151 | complement activation, classical pathway (GO:0006958) | 2.96118196 |
| 152 | positive regulation of digestive system process (GO:0060456) | 2.93808047 |
| 153 | peptide catabolic process (GO:0043171) | 2.92436430 |
| 154 | electron transport chain (GO:0022900) | 2.92404108 |
| 155 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.90409755 |
| 156 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.87870232 |
| 157 | sulfate transport (GO:0008272) | 2.87823969 |
| 158 | lipoprotein transport (GO:0042953) | 2.87547786 |
| 159 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87483597 |
| 160 | cellular response to vitamin (GO:0071295) | 2.86453291 |
| 161 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.84196957 |
| 162 | intestinal absorption (GO:0050892) | 11.3365862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.52744982 |
| 2 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.84616979 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.69181550 |
| 4 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.39787585 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.38250084 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.38045891 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.28001367 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.93942080 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.92295442 |
| 10 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.80634006 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.64318736 |
| 12 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.48965403 |
| 13 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.47311140 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17536549 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.06112119 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 11.7611034 |
| 17 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.89230045 |
| 18 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.85958068 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85189244 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81909239 |
| 21 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.81278606 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80370014 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79639120 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76387564 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75294970 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.75165269 |
| 27 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71478338 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.65983912 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64821077 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.63907131 |
| 31 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.56714575 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56611540 |
| 33 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.56195044 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45921016 |
| 35 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.42056653 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41345128 |
| 37 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.40723175 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40622858 |
| 39 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.40096838 |
| 40 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.39918716 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35085871 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31631717 |
| 43 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30760611 |
| 44 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.30252108 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29961373 |
| 46 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29000784 |
| 47 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28951710 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.28903357 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28894457 |
| 50 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28642169 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28239123 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27504116 |
| 53 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26493900 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25984172 |
| 55 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25325590 |
| 56 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25325590 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24836193 |
| 58 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24021529 |
| 59 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23830260 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23295732 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22571655 |
| 62 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.21926475 |
| 63 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.21611501 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19600847 |
| 65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17871884 |
| 66 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.16684583 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15302950 |
| 68 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.15181304 |
| 69 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.12552432 |
| 70 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.12009791 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11607787 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11587690 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11464355 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10076014 |
| 75 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.09303238 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09214087 |
| 77 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.08638539 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08156005 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.07940508 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07390109 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07094488 |
| 82 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.06620725 |
| 83 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05904909 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05834192 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05467776 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05434685 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05204561 |
| 88 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05164513 |
| 89 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02626092 |
| 90 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.02194030 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00456707 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00231622 |
| 93 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.00207042 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99994830 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.99932209 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99252479 |
| 97 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99069136 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98742723 |
| 99 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97966049 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97541320 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97488757 |
| 102 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97072954 |
| 103 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97017479 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96844681 |
| 105 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96474882 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96300870 |
| 107 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95689703 |
| 108 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.94299581 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93566014 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.93445293 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93165596 |
| 112 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.91860759 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91468320 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90559758 |
| 115 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.90347964 |
| 116 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.90246133 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89098427 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88319971 |
| 119 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88105217 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87618012 |
| 121 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.87605060 |
| 122 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.87069600 |
| 123 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86873177 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.86845258 |
| 125 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.86704757 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86567537 |
| 127 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86551409 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85712947 |
| 129 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85622497 |
| 130 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85449232 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85047267 |
| 132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84955988 |
| 133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.84943074 |
| 134 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.84690953 |
| 135 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83638623 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83482034 |
| 137 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.83129807 |
| 138 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83092965 |
| 139 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.82977223 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82830822 |
| 141 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82698071 |
| 142 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82684930 |
| 143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81820282 |
| 144 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.81678313 |
| 145 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.81560002 |
| 146 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81044924 |
| 147 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81017700 |
| 148 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80638219 |
| 149 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.79809286 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.79382702 |
| 151 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.79310269 |
| 152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79024175 |
| 153 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.78956436 |
| 154 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78401940 |
| 155 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.77493295 |
| 156 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.77481002 |
| 157 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76652259 |
| 158 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74087408 |
| 159 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.73622509 |
| 160 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73194625 |
| 161 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73093229 |
| 162 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.71332891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 7.95998010 |
| 2 | MP0005360_urolithiasis | 6.99369231 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.00005155 |
| 4 | MP0001873_stomach_inflammation | 3.81409691 |
| 5 | MP0000462_abnormal_digestive_system | 3.63063581 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.61081675 |
| 7 | MP0001346_abnormal_lacrimal_gland | 3.55069985 |
| 8 | MP0002876_abnormal_thyroid_physiology | 3.15932575 |
| 9 | MP0004264_abnormal_extraembryonic_tissu | 2.93217617 |
| 10 | MP0005367_renal/urinary_system_phenotyp | 2.86876071 |
| 11 | MP0000516_abnormal_urinary_system | 2.86876071 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.62067605 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.60713001 |
| 14 | MP0005310_abnormal_salivary_gland | 2.43629915 |
| 15 | MP0005409_darkened_coat_color | 2.28202368 |
| 16 | MP0000538_abnormal_urinary_bladder | 2.22926445 |
| 17 | MP0001348_abnormal_lacrimal_gland | 2.21523902 |
| 18 | MP0001663_abnormal_digestive_system | 2.16446051 |
| 19 | MP0008004_abnormal_stomach_pH | 2.12143113 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.08917738 |
| 21 | MP0005381_digestive/alimentary_phenotyp | 2.06563481 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.01085923 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 1.97177393 |
| 24 | MP0003252_abnormal_bile_duct | 1.94573994 |
| 25 | MP0003866_abnormal_defecation | 1.84296885 |
| 26 | MP0000613_abnormal_salivary_gland | 1.80090365 |
| 27 | * MP0010155_abnormal_intestine_physiology | 1.78873887 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.76628111 |
| 29 | MP0005166_decreased_susceptibility_to | 1.76147505 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.75407857 |
| 31 | MP0000537_abnormal_urethra_morphology | 1.75250468 |
| 32 | MP0000383_abnormal_hair_follicle | 1.75212518 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.72204620 |
| 34 | MP0004858_abnormal_nervous_system | 1.62737073 |
| 35 | MP0001664_abnormal_digestion | 1.53620402 |
| 36 | MP0003868_abnormal_feces_composition | 1.51426797 |
| 37 | MP0001485_abnormal_pinna_reflex | 1.50606167 |
| 38 | MP0000566_synostosis | 1.48200651 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.44244228 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.37893554 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.37187048 |
| 42 | MP0002098_abnormal_vibrissa_morphology | 1.33717671 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32841016 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.32590370 |
| 45 | MP0001188_hyperpigmentation | 1.32075387 |
| 46 | MP0004782_abnormal_surfactant_physiolog | 1.29469596 |
| 47 | MP0003879_abnormal_hair_cell | 1.29340269 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.28363774 |
| 49 | MP0000490_abnormal_crypts_of | 1.27920243 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.24775338 |
| 51 | MP0000470_abnormal_stomach_morphology | 1.23045501 |
| 52 | MP0002136_abnormal_kidney_physiology | 1.22282108 |
| 53 | MP0010352_gastrointestinal_tract_polyps | 1.22075555 |
| 54 | MP0008872_abnormal_physiological_respon | 1.21602211 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.18334661 |
| 56 | MP0005365_abnormal_bile_salt | 1.17296190 |
| 57 | MP0000685_abnormal_immune_system | 1.15978202 |
| 58 | MP0002118_abnormal_lipid_homeostasis | 1.09571376 |
| 59 | MP0005670_abnormal_white_adipose | 1.05814830 |
| 60 | MP0001849_ear_inflammation | 1.05087904 |
| 61 | MP0009840_abnormal_foam_cell | 1.04148788 |
| 62 | MP0003724_increased_susceptibility_to | 1.04129284 |
| 63 | MP0001790_abnormal_immune_system | 1.02883700 |
| 64 | MP0005387_immune_system_phenotype | 1.02883700 |
| 65 | * MP0001845_abnormal_inflammatory_respons | 1.02822229 |
| 66 | MP0009697_abnormal_copulation | 1.02699342 |
| 67 | MP0000427_abnormal_hair_cycle | 1.02140326 |
| 68 | MP0009785_altered_susceptibility_to | 1.01215036 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.99834547 |
| 70 | MP0005448_abnormal_energy_balance | 0.99579595 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98042370 |
| 72 | MP0000467_abnormal_esophagus_morphology | 0.97888976 |
| 73 | MP0004270_analgesia | 0.97786924 |
| 74 | MP0003787_abnormal_imprinting | 0.96927977 |
| 75 | MP0005535_abnormal_body_temperature | 0.95573512 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.95057417 |
| 77 | MP0002163_abnormal_gland_morphology | 0.94231692 |
| 78 | MP0005025_abnormal_response_to | 0.92122370 |
| 79 | MP0001756_abnormal_urination | 0.91292785 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.88765771 |
| 81 | MP0002938_white_spotting | 0.88459503 |
| 82 | MP0002138_abnormal_hepatobiliary_system | 0.87605359 |
| 83 | MP0004147_increased_porphyrin_level | 0.87528425 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.86145616 |
| 85 | MP0002971_abnormal_brown_adipose | 0.84566523 |
| 86 | MP0003436_decreased_susceptibility_to | 0.84325622 |
| 87 | MP0000579_abnormal_nail_morphology | 0.84033317 |
| 88 | MP0008469_abnormal_protein_level | 0.83428222 |
| 89 | MP0009115_abnormal_fat_cell | 0.80781345 |
| 90 | MP0005451_abnormal_body_composition | 0.79692897 |
| 91 | MP0000604_amyloidosis | 0.78561773 |
| 92 | MP0003303_peritoneal_inflammation | 0.78114829 |
| 93 | MP0003329_amyloid_beta_deposits | 0.77542234 |
| 94 | MP0009764_decreased_sensitivity_to | 0.75756586 |
| 95 | MP0001764_abnormal_homeostasis | 0.75435540 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.73197296 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 0.73190279 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.71812860 |
| 99 | MP0002396_abnormal_hematopoietic_system | 0.71719896 |
| 100 | MP0004947_skin_inflammation | 0.70230626 |
| 101 | MP0003191_abnormal_cellular_cholesterol | 0.69790737 |
| 102 | MP0006082_CNS_inflammation | 0.69771929 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.67154290 |
| 104 | MP0003123_paternal_imprinting | 0.66633306 |
| 105 | MP0001800_abnormal_humoral_immune | 0.65078802 |
| 106 | MP0000249_abnormal_blood_vessel | 0.64042349 |
| 107 | MP0000678_abnormal_parathyroid_gland | 0.63397345 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.62720091 |
| 109 | MP0001835_abnormal_antigen_presentation | 0.61361235 |
| 110 | MP0004510_myositis | 0.59508159 |
| 111 | MP0003718_maternal_effect | 0.59383782 |
| 112 | MP0002796_impaired_skin_barrier | 0.58059375 |
| 113 | MP0002006_tumorigenesis | 0.56605110 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.56515736 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.56400653 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.55439604 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.55194161 |
| 118 | MP0005000_abnormal_immune_tolerance | 0.54380287 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.53018207 |
| 120 | MP0001881_abnormal_mammary_gland | 0.52937282 |
| 121 | MP0005174_abnormal_tail_pigmentation | 0.52884574 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.52718665 |
| 123 | MP0002822_catalepsy | 0.51965552 |
| 124 | MP0005334_abnormal_fat_pad | 0.50067639 |
| 125 | MP0001270_distended_abdomen | 0.48919661 |
| 126 | MP0005165_increased_susceptibility_to | 0.47598353 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.47535054 |
| 128 | MP0003941_abnormal_skin_development | 0.47364456 |
| 129 | MP0000627_abnormal_mammary_gland | 0.47342574 |
| 130 | MP0005332_abnormal_amino_acid | 0.46103383 |
| 131 | MP0009333_abnormal_splenocyte_physiolog | 0.41765557 |
| 132 | MP0003878_abnormal_ear_physiology | 0.41727824 |
| 133 | MP0005377_hearing/vestibular/ear_phenot | 0.41727824 |
| 134 | MP0002132_abnormal_respiratory_system | 0.40473809 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.40323963 |
| 136 | MP0000609_abnormal_liver_physiology | 0.39587043 |
| 137 | MP0005671_abnormal_response_to | 0.39436200 |
| 138 | MP0001529_abnormal_vocalization | 0.38893446 |
| 139 | MP0000377_abnormal_hair_follicle | 0.37910099 |
| 140 | MP0003806_abnormal_nucleotide_metabolis | 0.34438485 |
| 141 | MP0003119_abnormal_digestive_system | 0.33856189 |
| 142 | MP0002095_abnormal_skin_pigmentation | 0.33731994 |
| 143 | MP0000703_abnormal_thymus_morphology | 0.33255436 |
| 144 | MP0009053_abnormal_anal_canal | 0.31752049 |
| 145 | MP0004484_altered_response_of | 0.31246923 |
| 146 | MP0004043_abnormal_pH_regulation | 0.31238381 |
| 147 | MP0010771_integument_phenotype | 0.29988093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.29701746 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.69864175 |
| 3 | Acanthocytosis (HP:0001927) | 5.16422208 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.11791969 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.10593601 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.10411742 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 4.47182474 |
| 8 | Ventricular fibrillation (HP:0001663) | 4.47075331 |
| 9 | Pustule (HP:0200039) | 4.33247350 |
| 10 | Microretrognathia (HP:0000308) | 4.19461951 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 3.97811941 |
| 12 | Hydroxyprolinuria (HP:0003080) | 3.97811941 |
| 13 | Nausea (HP:0002018) | 3.87710965 |
| 14 | Cheilitis (HP:0100825) | 3.86967919 |
| 15 | Abnormality of the gastric mucosa (HP:0004295) | 3.79908660 |
| 16 | Congenital sensorineural hearing impairment (HP:0008527) | 3.73129068 |
| 17 | Rectal prolapse (HP:0002035) | 3.67586193 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.64204467 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.64204467 |
| 20 | Malnutrition (HP:0004395) | 3.61294413 |
| 21 | Proximal tubulopathy (HP:0000114) | 3.50077441 |
| 22 | Premature loss of primary teeth (HP:0006323) | 3.41070973 |
| 23 | Hyperglycinuria (HP:0003108) | 3.40052479 |
| 24 | Thin bony cortex (HP:0002753) | 3.37164879 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.34306034 |
| 26 | Wide cranial sutures (HP:0010537) | 3.32664074 |
| 27 | Autoimmune hemolytic anemia (HP:0001890) | 3.25273821 |
| 28 | Nephrolithiasis (HP:0000787) | 3.20963708 |
| 29 | Amniotic constriction ring (HP:0009775) | 3.19825504 |
| 30 | Abnormality of placental membranes (HP:0011409) | 3.19825504 |
| 31 | Onycholysis (HP:0001806) | 3.16493836 |
| 32 | Plantar hyperkeratosis (HP:0007556) | 3.15950398 |
| 33 | Xanthomatosis (HP:0000991) | 3.15748957 |
| 34 | Poikilocytosis (HP:0004447) | 3.14794130 |
| 35 | Increased purine levels (HP:0004368) | 3.08526790 |
| 36 | Hyperuricemia (HP:0002149) | 3.08526790 |
| 37 | Eczematoid dermatitis (HP:0000976) | 3.05455864 |
| 38 | Nasolacrimal duct obstruction (HP:0000579) | 3.04121850 |
| 39 | Decreased circulating renin level (HP:0003351) | 3.03887689 |
| 40 | Hypophosphatemia (HP:0002148) | 3.00325699 |
| 41 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.97590537 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.93274953 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.93274953 |
| 44 | Abnormality of the lacrimal duct (HP:0011481) | 2.92013176 |
| 45 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.89939631 |
| 46 | Villous atrophy (HP:0011473) | 2.89939631 |
| 47 | Pili torti (HP:0003777) | 2.89216541 |
| 48 | Abnormality of urine glucose concentration (HP:0011016) | 2.88164274 |
| 49 | Glycosuria (HP:0003076) | 2.88164274 |
| 50 | Alkalosis (HP:0001948) | 2.86179151 |
| 51 | Palpitations (HP:0001962) | 2.85876412 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.85621575 |
| 53 | Abdominal distention (HP:0003270) | 2.85588630 |
| 54 | Milia (HP:0001056) | 2.80928063 |
| 55 | Steatorrhea (HP:0002570) | 2.80888298 |
| 56 | Facial shape deformation (HP:0011334) | 2.80486464 |
| 57 | Potter facies (HP:0002009) | 2.80486464 |
| 58 | Ankyloglossia (HP:0010296) | 2.80284535 |
| 59 | Hyperparathyroidism (HP:0000843) | 2.79216217 |
| 60 | Poikiloderma (HP:0001029) | 2.76967635 |
| 61 | Fragile skin (HP:0001030) | 2.74076259 |
| 62 | Syncope (HP:0001279) | 2.72252917 |
| 63 | Glomerulonephritis (HP:0000099) | 2.70647532 |
| 64 | Metabolic alkalosis (HP:0200114) | 2.69962890 |
| 65 | Confusion (HP:0001289) | 2.69841398 |
| 66 | Woolly hair (HP:0002224) | 2.68791169 |
| 67 | Fat malabsorption (HP:0002630) | 2.67923228 |
| 68 | Mitochondrial inheritance (HP:0001427) | 2.67805517 |
| 69 | Abnormality of vitamin B metabolism (HP:0004340) | 2.67690837 |
| 70 | Periodontitis (HP:0000704) | 2.66382125 |
| 71 | Abnormality of purine metabolism (HP:0004352) | 2.65846715 |
| 72 | Chronic diarrhea (HP:0002028) | 2.64636665 |
| 73 | Hyperammonemia (HP:0001987) | 2.64078801 |
| 74 | Megaloblastic anemia (HP:0001889) | 2.62207909 |
| 75 | Hepatocellular necrosis (HP:0001404) | 2.59980170 |
| 76 | Abnormality of complement system (HP:0005339) | 2.56473744 |
| 77 | Xerostomia (HP:0000217) | 2.53285314 |
| 78 | Hyperactive renin-angiotensin system (HP:0000841) | 2.52878328 |
| 79 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52264212 |
| 80 | Alacrima (HP:0000522) | 2.51096142 |
| 81 | Complement deficiency (HP:0004431) | 2.47985766 |
| 82 | Ridged nail (HP:0001807) | 2.45886914 |
| 83 | Abnormal biliary tract morphology (HP:0012440) | 2.45826180 |
| 84 | Enlarged epiphyses (HP:0010580) | 2.41230218 |
| 85 | Palmoplantar hyperkeratosis (HP:0000972) | 2.40741539 |
| 86 | Acute encephalopathy (HP:0006846) | 2.38745422 |
| 87 | Hypoplasia of dental enamel (HP:0006297) | 2.38083547 |
| 88 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37747751 |
| 89 | Focal segmental glomerulosclerosis (HP:0000097) | 2.37666801 |
| 90 | Lipid accumulation in hepatocytes (HP:0006561) | 2.36008873 |
| 91 | Widely patent fontanelles and sutures (HP:0004492) | 2.35930921 |
| 92 | Recurrent fungal infections (HP:0002841) | 2.35441211 |
| 93 | Increased hepatocellular lipid droplets (HP:0006565) | 2.35028894 |
| 94 | Abnormality of the nasolacrimal system (HP:0000614) | 2.35013034 |
| 95 | Nephritis (HP:0000123) | 2.33385800 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.32744021 |
| 97 | Decreased lacrimation (HP:0000633) | 2.32589526 |
| 98 | Hypotension (HP:0002615) | 2.30324924 |
| 99 | Abnormal hemoglobin (HP:0011902) | 2.30262859 |
| 100 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26621649 |
| 101 | Delayed epiphyseal ossification (HP:0002663) | 2.26549260 |
| 102 | Hypolipoproteinemia (HP:0010981) | 2.26466908 |
| 103 | Hemorrhage of the eye (HP:0011885) | 2.26059873 |
| 104 | Preauricular pit (HP:0004467) | 2.24491822 |
| 105 | Periauricular skin pits (HP:0100277) | 2.24491822 |
| 106 | Aplasia cutis congenita (HP:0001057) | 2.23636824 |
| 107 | Hyperphosphatemia (HP:0002905) | 2.23192802 |
| 108 | Cerebral palsy (HP:0100021) | 2.22562643 |
| 109 | Trismus (HP:0000211) | 2.22010604 |
| 110 | Pancreatitis (HP:0001733) | 2.21725285 |
| 111 | Hepatic necrosis (HP:0002605) | 2.21527122 |
| 112 | Palmar hyperkeratosis (HP:0010765) | 2.21291533 |
| 113 | Colon cancer (HP:0003003) | 2.20808459 |
| 114 | Abnormal glucose tolerance (HP:0001952) | 2.19927838 |
| 115 | Metabolic acidosis (HP:0001942) | 2.19438447 |
| 116 | Epidermoid cyst (HP:0200040) | 2.19292353 |
| 117 | Ventricular arrhythmia (HP:0004308) | 2.18366211 |
| 118 | Hyperphosphaturia (HP:0003109) | 2.17876879 |
| 119 | Dehydration (HP:0001944) | 2.17633884 |
| 120 | Increased CSF lactate (HP:0002490) | 2.17567240 |
| 121 | Protuberant abdomen (HP:0001538) | 2.16040614 |
| 122 | Acute necrotizing encephalopathy (HP:0006965) | 2.15524105 |
| 123 | Abnormality of the costochondral junction (HP:0000919) | 2.15450994 |
| 124 | Pigmentary retinal degeneration (HP:0001146) | 2.15039688 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 2.14041701 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14041701 |
| 127 | Gout (HP:0001997) | 2.13459292 |
| 128 | B lymphocytopenia (HP:0010976) | 2.10006667 |
| 129 | Abnormality of B cell number (HP:0010975) | 2.10006667 |
| 130 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.09680175 |
| 131 | Mixed hearing impairment (HP:0000410) | 2.07630539 |
| 132 | Abnormality of magnesium homeostasis (HP:0004921) | 2.07432405 |
| 133 | Gingivitis (HP:0000230) | 2.02461913 |
| 134 | Increased mean platelet volume (HP:0011877) | 2.01102717 |
| 135 | Growth hormone excess (HP:0000845) | 2.00835049 |
| 136 | Abnormality of the preputium (HP:0100587) | 2.00511158 |
| 137 | Gastrointestinal dysmotility (HP:0002579) | 1.99459996 |
| 138 | Subcapsular cataract (HP:0000523) | 1.98485840 |
| 139 | Abnormality of vitamin metabolism (HP:0100508) | 1.97519585 |
| 140 | Intrahepatic cholestasis (HP:0001406) | 1.97458013 |
| 141 | Renal tubular acidosis (HP:0001947) | 1.97286756 |
| 142 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.97012622 |
| 143 | Atrophic scars (HP:0001075) | 1.96996581 |
| 144 | Irritability (HP:0000737) | 1.95615122 |
| 145 | Gastrointestinal inflammation (HP:0004386) | 1.95270708 |
| 146 | Posterior subcapsular cataract (HP:0007787) | 1.95107625 |
| 147 | Fragile nails (HP:0001808) | 1.95098772 |
| 148 | Gastrointestinal stroma tumor (HP:0100723) | 1.93198528 |
| 149 | Severe combined immunodeficiency (HP:0004430) | 1.92258399 |
| 150 | Reduced antithrombin III activity (HP:0001976) | 1.90262521 |
| 151 | Biliary tract neoplasm (HP:0100574) | 1.89593982 |
| 152 | Micronodular cirrhosis (HP:0001413) | 1.86804015 |
| 153 | CNS demyelination (HP:0007305) | 1.86789613 |
| 154 | Progressive macrocephaly (HP:0004481) | 1.86550528 |
| 155 | Abnormal urine phosphate concentration (HP:0012599) | 1.86323129 |
| 156 | Hypercortisolism (HP:0001578) | 1.85198409 |
| 157 | Prolonged QT interval (HP:0001657) | 1.82662440 |
| 158 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.82046873 |
| 159 | Multiple lipomas (HP:0001012) | 1.80377068 |
| 160 | Emphysema (HP:0002097) | 1.79625734 |
| 161 | Glomerulosclerosis (HP:0000096) | 1.78995806 |
| 162 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76440920 |
| 163 | Skin rash (HP:0000988) | 1.75455478 |
| 164 | Hypocalcemia (HP:0002901) | 1.72617392 |
| 165 | Paresthesia (HP:0003401) | 1.71963465 |
| 166 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71722201 |
| 167 | Renal tubular dysfunction (HP:0000124) | 1.70079795 |
| 168 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69333564 |
| 169 | Hypoalbuminemia (HP:0003073) | 1.69323004 |
| 170 | Abnormal albumin level (HP:0012116) | 1.69323004 |
| 171 | Symptomatic seizures (HP:0011145) | 1.69046160 |
| 172 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.67811015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.74982181 |
| 2 | LMTK2 | 6.33127662 |
| 3 | NME1 | 5.96439628 |
| 4 | FRK | 5.24876485 |
| 5 | ERN1 | 4.76146311 |
| 6 | MST4 | 4.57512124 |
| 7 | NUAK1 | 3.17199692 |
| 8 | RIPK1 | 3.12073111 |
| 9 | PRKG2 | 2.71238498 |
| 10 | MST1R | 2.40287833 |
| 11 | CASK | 2.01880537 |
| 12 | TESK2 | 1.97751432 |
| 13 | TTK | 1.97457618 |
| 14 | MAPK15 | 1.88206694 |
| 15 | AKT3 | 1.82017000 |
| 16 | PBK | 1.81384915 |
| 17 | MAP4K1 | 1.81120656 |
| 18 | EPHB2 | 1.78326582 |
| 19 | GRK6 | 1.76539475 |
| 20 | MAP3K14 | 1.74295517 |
| 21 | PDK2 | 1.69681365 |
| 22 | MAP2K2 | 1.69428275 |
| 23 | MAP3K10 | 1.54956335 |
| 24 | ERBB2 | 1.46245006 |
| 25 | MAP2K6 | 1.39710412 |
| 26 | TNIK | 1.32864912 |
| 27 | MET | 1.29762541 |
| 28 | EPHA2 | 1.20716700 |
| 29 | PRPF4B | 1.20644567 |
| 30 | FGFR3 | 1.17326798 |
| 31 | MYLK | 1.16970999 |
| 32 | MAP3K13 | 1.16305018 |
| 33 | MAP3K1 | 1.15360317 |
| 34 | TSSK6 | 1.13852968 |
| 35 | BCR | 1.12546051 |
| 36 | PTK6 | 1.11466362 |
| 37 | MAPK11 | 1.11449359 |
| 38 | CDK8 | 1.10867091 |
| 39 | EPHA4 | 1.04860419 |
| 40 | STK39 | 1.04135772 |
| 41 | MAP3K11 | 1.02951982 |
| 42 | CDC42BPA | 1.01817445 |
| 43 | CDK12 | 1.00015777 |
| 44 | TYK2 | 0.96421964 |
| 45 | PASK | 0.94827327 |
| 46 | TESK1 | 0.93034212 |
| 47 | IRAK1 | 0.92228948 |
| 48 | TAOK3 | 0.92146317 |
| 49 | LATS1 | 0.91591298 |
| 50 | CCNB1 | 0.88009461 |
| 51 | FGFR4 | 0.87146804 |
| 52 | PDPK1 | 0.87007849 |
| 53 | RPS6KB2 | 0.86264093 |
| 54 | VRK1 | 0.86185555 |
| 55 | MAP3K2 | 0.86112923 |
| 56 | IRAK3 | 0.85872102 |
| 57 | BMPR1B | 0.85618713 |
| 58 | MAP3K12 | 0.82400746 |
| 59 | PIK3CA | 0.81916353 |
| 60 | CDK19 | 0.80550744 |
| 61 | YES1 | 0.79618960 |
| 62 | AURKB | 0.78662939 |
| 63 | ERBB4 | 0.73942767 |
| 64 | DDR2 | 0.73737091 |
| 65 | BRD4 | 0.71850423 |
| 66 | PRKACG | 0.69332840 |
| 67 | NLK | 0.68008685 |
| 68 | MELK | 0.67896592 |
| 69 | CAMK2B | 0.67521791 |
| 70 | PRKCI | 0.67159109 |
| 71 | PTK2 | 0.66702697 |
| 72 | DAPK2 | 0.65053318 |
| 73 | DYRK1B | 0.64894490 |
| 74 | KIT | 0.64604117 |
| 75 | CDK9 | 0.64442024 |
| 76 | CAMK2G | 0.63936037 |
| 77 | PRKCZ | 0.62338301 |
| 78 | PDK1 | 0.62336620 |
| 79 | TLK1 | 0.61979023 |
| 80 | TAOK1 | 0.61485399 |
| 81 | PRKAA2 | 0.61115240 |
| 82 | MATK | 0.60833468 |
| 83 | FER | 0.60553295 |
| 84 | SCYL2 | 0.58769646 |
| 85 | PIM1 | 0.56638801 |
| 86 | CSK | 0.56497353 |
| 87 | ZAP70 | 0.55100558 |
| 88 | CHUK | 0.54691068 |
| 89 | SYK | 0.54112287 |
| 90 | RIPK4 | 0.54004452 |
| 91 | BMPR2 | 0.53550383 |
| 92 | JAK3 | 0.53486570 |
| 93 | EIF2AK2 | 0.51449313 |
| 94 | IKBKE | 0.50448635 |
| 95 | BTK | 0.50062842 |
| 96 | CDK3 | 0.49829843 |
| 97 | RET | 0.49482820 |
| 98 | EPHB1 | 0.49122166 |
| 99 | EPHA3 | 0.48696035 |
| 100 | CSF1R | 0.46572848 |
| 101 | MAP3K7 | 0.46425269 |
| 102 | TRIM28 | 0.45919373 |
| 103 | KSR1 | 0.45707075 |
| 104 | DYRK3 | 0.43397854 |
| 105 | CDK7 | 0.43116619 |
| 106 | PLK3 | 0.42933485 |
| 107 | INSRR | 0.42593553 |
| 108 | FYN | 0.42148842 |
| 109 | ITK | 0.42045386 |
| 110 | KSR2 | 0.41941979 |
| 111 | TRIB3 | 0.41606386 |
| 112 | PRKCD | 0.41000407 |
| 113 | BMX | 0.39161488 |
| 114 | FGR | 0.38196621 |
| 115 | CAMK2D | 0.37855582 |
| 116 | OXSR1 | 0.36792128 |
| 117 | STK38L | 0.36780166 |
| 118 | ABL2 | 0.36745425 |
| 119 | IRAK4 | 0.35649530 |
| 120 | GRK1 | 0.35575138 |
| 121 | PLK1 | 0.35259641 |
| 122 | SIK3 | 0.35216975 |
| 123 | LYN | 0.35041034 |
| 124 | STK3 | 0.34956349 |
| 125 | STK10 | 0.34935230 |
| 126 | MAP2K1 | 0.34581456 |
| 127 | MAP3K8 | 0.34307679 |
| 128 | SMG1 | 0.33072545 |
| 129 | ICK | 0.32044442 |
| 130 | MAPKAPK2 | 0.31381966 |
| 131 | STK11 | 0.30887830 |
| 132 | TBK1 | 0.30446823 |
| 133 | NEK6 | 0.30138071 |
| 134 | TEC | 0.29947379 |
| 135 | LCK | 0.29834037 |
| 136 | PRKDC | 0.29107504 |
| 137 | PRKCQ | 0.28359580 |
| 138 | GRK5 | 0.27563245 |
| 139 | JAK1 | 0.27040545 |
| 140 | CDK6 | 0.26850900 |
| 141 | PAK4 | 0.26667773 |
| 142 | LRRK2 | 0.26151310 |
| 143 | SRPK1 | 0.25446883 |
| 144 | CSNK1A1 | 0.25423177 |
| 145 | SRC | 0.25225974 |
| 146 | ATM | 0.24876184 |
| 147 | PDGFRA | 0.24365094 |
| 148 | STK24 | 0.24293281 |
| 149 | JAK2 | 0.23674097 |
| 150 | KDR | 0.23644488 |
| 151 | PRKCA | 0.23529751 |
| 152 | NEK2 | 0.23506452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.65384122 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.26885881 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 4.06666450 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.90284725 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.45539280 |
| 6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.13475923 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.07901230 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.63715295 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.38783394 |
| 10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.38670364 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.24951681 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.17069587 |
| 13 | Galactose metabolism_Homo sapiens_hsa00052 | 2.12020873 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.08168045 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04241210 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.01663184 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.95925703 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.88442284 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65391893 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.63502973 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58820414 |
| 22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.54587038 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51448787 |
| 24 | Allograft rejection_Homo sapiens_hsa05330 | 1.45537157 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.43183373 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.37145997 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30726458 |
| 28 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.30344756 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29298310 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24431897 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22020147 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19581250 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.19251843 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18489099 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.18416100 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16181665 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.15839058 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15675963 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.11604583 |
| 40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.10944467 |
| 41 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10268497 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04670317 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01939916 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99560748 |
| 45 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97648288 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91716882 |
| 47 | Ribosome_Homo sapiens_hsa03010 | 0.90851707 |
| 48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.89272821 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88041875 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85312778 |
| 51 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82814383 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82221699 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79682616 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75779039 |
| 55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74760213 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73501244 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71520825 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.69047332 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67691430 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.62040532 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61213900 |
| 62 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57777264 |
| 63 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56868148 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56836285 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56830732 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56260344 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55277569 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55184550 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.53154251 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.52840417 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.52726107 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52562891 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50864403 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50831499 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.48219498 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47380467 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.47317279 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46888922 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46458296 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45848944 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44545181 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42903435 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.42645993 |
| 84 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41180443 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41090773 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.38737464 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.37712597 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.37500441 |
| 89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.37346372 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.36913385 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34502473 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33801595 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32782382 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32699186 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30569359 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29396052 |
| 97 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29120228 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.28977342 |
| 99 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28180807 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27891401 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27853921 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.25194805 |
| 103 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24858585 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23060296 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22013244 |
| 106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.20639961 |
| 107 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20372259 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19810668 |
| 109 | Leishmaniasis_Homo sapiens_hsa05140 | 0.19757527 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.18918899 |
| 111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17010934 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16816849 |
| 113 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.16661741 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.16639109 |
| 115 | Salivary secretion_Homo sapiens_hsa04970 | 0.16426654 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.16282524 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.15059944 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.14717324 |
| 119 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.13520712 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.11405581 |
| 121 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11233454 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.11228105 |
| 123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.10979811 |
| 124 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.09810984 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09721225 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.09506202 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08730396 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.08520570 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.06708524 |
| 130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.06318785 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.06059525 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.04804914 |
| 133 | Insulin secretion_Homo sapiens_hsa04911 | 0.04329080 |
| 134 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.04109362 |
| 135 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.02846711 |

